Answer
When assessing driving ability during abacavir + lamivudine treatment, consider the patient's clinical status and the medicine's adverse reaction profile, as no studies on driving or operating machinery have been performed.
Sources for this answer
- Abacavir/Lamivudine Dr. Reddy's 600 mg/300 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 4Document updated
Sources checked